- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04661553
Mueller Polarimetric Colposcopy for High-performance Detection of Cervical Changes During Pregnancy (COLPOTERME)
Mueller Polarimetric Colposcopy for High-performance Detection of Cervical Changes During Pregnancy (COLPOTERME)
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Interventional research protocol involving the human person relating to a medical device. This is a prospective, not randomized, monocentric study. Prematurity accounts for around 11% of births worldwide. In France, around 60,000 children (7.4%) are born each year prematurely. The term of gestation has a strong impact on mortality, severe neonatal morbidity, and child development. For this reason, premature birth represents a major public health issue. The means to reliably predict a premature birth are still ineffective. The medical device used in this research is a Mueller polarimetric colposcope which appears to be a powerful tool for evaluating the process of remodeling of cervical microstructure during pregnancy.
Mueller polarimetric imaging is the only technique that enables obtaining the comprehensive polarimetric characterization of a sample. Two groups are considered for this study: i) patients at low risk of premature birth (Group 1); ii) patients at high risk of premature birth (Group 2).
This study's main objective is to determine, for the two groups of patients, the best "polarimetric biomarkers" which make it possible to define an optimal "polarimetric score" reflecting the state of the cervical microstructure throughout its remodeling process during pregnancy.
This "Polarimetric Score" will be able to predict the term of childbirth and used as a screening tool for prematurity.
Study Type
Enrollment (Anticipated)
Phase
- Not Applicable
Contacts and Locations
Study Contact
- Name: Elodie DEBRAS, Dr
- Phone Number: 01 45 21 76 05
- Email: elodie.debras@aphp.fr
Study Contact Backup
- Name: Angelo PIERANGELO, Dr
- Phone Number: 01 46 69 43 69
- Email: angelo.pierangelo@polytechnique.edu
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Major patient.
- Single pregnancy.
- Baseline ≥ 20 amenorrhea week and <37 amenorrhea week.
- Dating obtained by ultrasound of the 1st trimester.
Written and informed consent.
- Group 1 (low risk):
Asymptomatic patient benefiting from usual follow-up in the maternity hospital.
> Group 2 (high risk): Symptomatic patient with cervical changes objectified by endovaginal ultrasound of the cervix with an effective length of <20mm.
Asymptomatic patient with a history of premature delivery or late miscarriage and cervical changes objectified by endovaginal ultrasound of the cervix with an effective length of <20mm."
Exclusion Criteria:
- Known uterine malformation or suspected uterine malformation.
- Pregnancy circled.
- Premature rupture of membranes.
- Suspicion of chorioamnionitis.
- Abundant active bleeding hindering the visualization of the cervix.
- History of conization.
- Imminent childbirth.
- Known medical indication at a birth <37 amenorrhea week (severe pre-eclampsia, severe intrauterine growth retardation, hemorrhagic placenta previa, fetal malformations,….).
- Examination of the cervix under speculum not possible.
- Lack of social coverage (AME).
- Limited understanding.
Participation in another intervention research.
> Group1 (Low risk):
- History of spontaneous premature labor.
- History of late miscarriage.
- History of premature rupture of membranes."
Study Plan
How is the study designed?
Design Details
- Primary Purpose: DIAGNOSTIC
- Allocation: NON_RANDOMIZED
- Interventional Model: PARALLEL
- Masking: NONE
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
EXPERIMENTAL: Group1: patients with a low risk of premature birth
Asymptomatic patient receiving usual follow-up in the maternity ward.
|
Determination of the best "polarimetric biomarkers" reflecting the status of the cervical microstructure throughout its remodeling process due to the pregnancy in a population with a low-risk premature birth.
This "polarimetric biomarkers" should make it possible to accurately determine the time remaining before childbirth for a normal pregnancy and, therefore, to monitor the regular advancement of the gestation.
|
EXPERIMENTAL: Group2: patients with a high risk of premature birth
Symptomatic patients with cervical changes objectified by endovaginal ultrasound of the cervix with length <20mm.
Asymptomatic patients with a history of premature delivery or late miscarriage and cervical changes objectified by endovaginal ultrasound of the cervix with length <20mm.
|
Determination of the best "polarimetric biomarkers" reflecting the status of the cervical microstructure throughout its remodeling process due to the pregnancy in a population at high-risk of preterm birth. This "polarimetric biomarkers" should make it possible to accurately determine the time remaining before childbirth for an abnormal pregnancy and, therefore, to predict premature childbirth. |
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Polarimetric parameters in population with a low-risk of premature birth
Time Frame: 6 months
|
The principal outcome will be determining the best "polarimetric biomarkers" able to monitor and quantify the uterine cervix's modifications in a population with a low risk of premature birth. Specifically, the "polarimetric biomarkers" are the most relevant polarimetric parameters (or a combination of them) characterizing the cervical microstructure modifications during a normal pregnancy. They can be the main polarimetric parameters obtained from the measured Mueller matrices using different algebraic methods. One example of a polarimetric parameter that can be assessed is the Phase Retardance, measured in degrees at different wavelengths. It characterizes the anisotropy of the tissue. |
6 months
|
Polarimetric biomarkers in population with a low-risk of premature birth
Time Frame: 6 months
|
A polarimetric parameter that can be assessed is the azimuth of the Phase Retardance, measured in degrees at different wavelengths.
It characterizes the orientations of the microscopic fibrous structures (such as the collagen) in the tissue.
|
6 months
|
Parameters Polarimetric in population with a low-risk of premature birth
Time Frame: 6 months
|
A polarimetric parameter that can be assessed is the Depolarization, measured in arbitrary units at different wavelengths.
It characterizes the scattering properties of the tissue.
|
6 months
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Polarimetric parameters in population with a high-risk of premature birth
Time Frame: 6 months
|
A polarimetric parameter that can be assessed is the azimuth of the Phase Retardance, measured in degrees at different wavelengths.
It characterizes the orientations of the microscopic fibrous structures (such as the collagen) in the tissue.
|
6 months
|
Polarimetric biomarkers in population with a high-risk of premature birth
Time Frame: 6 months
|
A polarimetric parameter that can be assessed is the Depolarization, measured in arbitrary units at different wavelengths.
It characterizes the scattering properties of the tissue.
|
6 months
|
Parameters polarimetric in population with a high-risk of premature birth
Time Frame: 6 months
|
The principal outcome will be determining the best "polarimetric biomarkers" able to monitor and quantify the uterine cervix's modifications in a population with a high risk of premature birth. Specifically, the "polarimetric biomarkers" are the most relevant polarimetric parameters (or a combination of them) characterizing the cervical microstructure modifications during a normal pregnancy. They can be the main polarimetric parameters obtained from the measured Mueller matrices using different algebraic methods. One example of a polarimetric parameter that can be assessed is the Phase Retardance, measured in degrees at different wavelengths. It characterizes the anisotropy of the tissue. |
6 months
|
Collaborators and Investigators
Investigators
- Principal Investigator: Elodie DEBRAS, Dr, Obstetrics gynecology department - Bicetre hospital, Kremlin Bicetre, France
Study record dates
Study Major Dates
Study Start (ANTICIPATED)
Primary Completion (ANTICIPATED)
Study Completion (ANTICIPATED)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (ACTUAL)
Study Record Updates
Last Update Posted (ACTUAL)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- APHP191010
- 2020-A01932-37 (REGISTRY: IDRCB)
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Premature Birth
-
Shaare Zedek Medical CenterTerminatedPremature Birth of NewbornIsrael
-
University of VirginiaCompletedPremature Birth of NewbornUnited States
-
Case Western Reserve UniversityCompleted
-
University of California, San FranciscoUniversity of California, San Diego; University of California, Los Angeles; Kaiser...CompletedPremature Birth of NewbornUnited States
-
Universitaire Ziekenhuizen KU LeuvenKU LeuvenUnknownPremature Birth of NewbornBelgium
-
Universidad Complutense de MadridCompletedPremature Birth of Newborn
-
Indiana UniversityCompletedPremature LaborUnited States
-
Washington University School of MedicineUniversity of Southern CaliforniaCompletedPremature Birth of NewbornUnited States
-
Vestre Viken Hospital TrustHaukeland University HospitalActive, not recruiting
-
University of ArkansasCompletedPremature Birth of NewbornUnited States
Clinical Trials on Mueller's polarimetric colposcopy "Group 1"
-
Oslo University HospitalNorwegian Fund for Postgraduate Training in PhysiotherapyCompletedHealth-Related Quality of LifeNorway
-
Arkansas Children's Hospital Research InstituteRecruiting
-
Ichnos Sciences SAGlenmark Pharmaceuticals S.A.CompletedModerate to Severe Atopic DermatitisUnited States, Canada, Czechia, Germany, Poland
-
Marmara UniversityCompletedStair up and Down, Amputation | Amputation,Stair up and DownTurkey
-
Shanghai General Hospital, Shanghai Jiao Tong University...UnknownRetinal Detachment | High Myopia | Macular HolesChina
-
Biruni UniversityCompleted
-
Weill Medical College of Cornell UniversityTerminatedChronic Obstructive Pulmonary Disease | COPDUnited States
-
Biotronik SE & Co. KGBiotronik Japan, Inc.RecruitingImplantable Cardioverter Defibrillator(ICD)Japan
-
Riphah International UniversityCompleted
-
Hospital Universitario Central de AsturiasRecruiting